Citigroup’s PetMed Express PETS Stock Holding History

Citigroup’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-135,000	Closed	-$2.69M	–	6207
2022 Q2	$2.69M	Buy	+135,000	New	+$3.02M	﹤0.01%	1904

Other funds holding PETS

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SPH

Steel Partners Holdings New York $78M AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return

Citigroup's PETS Position: Q2 2026 in Review

Citigroup reduced its PetMed Express (PETS) stake by 97% in Q2 2026, selling an estimated $543 and leaving 9 shares worth $17. The position accounts for ﹤0.01% of the portfolio, ranked #5583.

Citigroup first reported a position in PETS in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.67M in Q4 2019. 50 funds tracked by Wall St. Rank hold PETS as of Q2 2026.

Citigroup held 9 shares of PetMed Express worth $17 as of Q2 2026.
Citigroup sold 256 PetMed Express shares in Q2 2026, an estimated $543.
PetMed Express made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #5583 holding.
Citigroup first reported a position in PetMed Express in Q2 2013 and has held it in 52 quarters since.
Citigroup's PetMed Express position peaked at $5.67M in Q4 2019.
50 funds tracked by Wall St. Rank held PetMed Express as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.